TMDX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
TMDX is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 who is impatient and wants an immediate decision. The stock has some positive medium-term growth support from bullish analysts, but the current price action is mixed to weak, insider selling is elevated, and there is no strong proprietary buy signal today. I would not call it a good buy at this moment; the better call is to hold off and wait for clearer strength or a cleaner entry.
The technical picture is mixed and currently leans bearish in the near term. MACD is positive and expanding, which is constructive, but RSI_6 at 38.355 shows momentum is still weak and not yet oversold enough to signal a clear reversal. The moving averages are bearish with SMA_200 > SMA_20 > SMA_5, indicating the broader trend is still under pressure. Price is sitting almost exactly at the pivot of 66.644, with immediate resistance at 70.365 and support at 62.924. The stock trend model also points to weakness over the next week and month, suggesting limited short-term upside from current levels.
["Several analysts still keep Buy/Outperform-style ratings despite cutting targets, showing long-term confidence remains in the story.", "Piper Sandler and TD Cowen continue to see long-term growth drivers ahead and recommend using pullbacks as entry opportunities.", "MACD is improving, which can support a rebound if buying momentum continues.", "No negative news in the last week, so there is no fresh event-driven breakdown."]
["Recent analyst price target cuts were sharp across the board after Q1 misses and trial enrollment concerns.", "Stifel downgraded to Hold and lowered its target, explicitly citing near-term weakness in the heart market.", "Insiders are selling, and the selling amount increased 186.38% over the last month.", "No recent news catalysts in the last week to reaccelerate sentiment.", "The stock trend model suggests negative performance over the next week and month.", "No AI Stock Picker or SwingMax buy signal is present today."]
No usable latest-quarter financial snapshot was provided due to a data error, but the analyst commentary indicates Q1 revenue and earnings missed expectations, and sales came in slightly below consensus. Management reiterated full-year revenue guidance, which is a constructive sign, but the immediate quarterly growth readout was weak and did not calm the market.
Analyst sentiment is mixed to moderately positive over the long term, but clearly weaker than before. The trend over the last month shows multiple target cuts after the Q1 report. Needham, TD Cowen, Piper Sandler, Canaccord, and Baird remain bullish or constructive, while Stifel is on Hold and Oppenheimer downgraded to Perform. The pro case is that several firms still believe in the company’s long-term growth drivers and execution. The con case is that near-term growth has softened, targets have been reset lower, and some analysts are waiting for a clearer narrative before getting aggressive. Overall Wall Street view is cautiously constructive, but not strong enough to make this an immediate buy.
